Latest Global Markets News

Macquarie Bank Limited has posted a robust FY2026 result, with net profit attributable to ordinary equity holders soaring 74% to AUD 6.011 billion, underpinned by strong performances in its Banking and Financial Services and Commodities and Global Markets divisions.

Macquarie Group (ASX: MQG) reported a 30% jump in FY2026 net profit to A$4.85 billion, driven by growth across all divisions and bolstered by strategic investments in AI and sustainability. The board declared a total dividend of A$7 per share and maintained a strong capital position amid ongoing regulatory remediation.

Evolution Energy Minerals (ASX:EV1) is set to start drilling at its Chikundo Copper Project in June 2026 despite assay delays, while progressing the Chilalo Graphite Project towards first production in October 2027 with a modular development plan and clear funding milestones.

Mt Malcolm Mines NL has revised its rights issue, lowering the price to $0.007 per share and adjusting the offer ratio to raise $1.81 million. The funds will support a processing plant feasibility study and advance exploration at its Leonora projects.

Noxopharm is gearing up for a pivotal pre-IND meeting with the US FDA, enlisting global CRO Novotech to sharpen its regulatory approach for SOF-SKN, a drug targeting autoimmune skin diseases.

Regis Resources and Vault Minerals have agreed to merge, creating Australia's third-largest ASX-listed gold producer with over 700,000 ounces annual output and a diversified asset base.

FBR Limited secured its first overseas Mantis welding robot sale, launched the Firehawk refractory robot, and expanded its Wall as a Service footprint in Victoria, while navigating a cash balance under $700,000.

RocketBoots has secured a significant A$3.3 million activation contract with a tier-one multinational retailer and reported over 50% growth in its early sales pipeline, supported by a strong cash position of A$5 million.

Coppermoly Limited has expanded its critical minerals footprint with the full acquisition of the Wyemandoo Project in Western Australia, while deferring Queensland geophysical surveys due to resource availability. The new project offers exposure to high-grade tungsten, rubidium, titanium, and tantalum, aligning with soaring global demand and prices.

Omni Bridgeway reports strong investment activity and a robust pipeline for Q3 2026, maintaining solid returns and cost discipline amid global market volatility.

Epsilon Healthcare has achieved its highest quarterly receipts ever with $3.14 million in Q1 2026, driven by strong expansion across contract manufacturing, clinics, and pharmacy operations.

Lindian Resources has begun full-scale construction at its Kangankunde Rare Earths Project and secured the SARECO Mixed Rare Earth Carbonate facility in Kazakhstan, positioning itself as a rare earths producer with downstream processing capabilities.